Perceived barriers to self-collected HPV testing for cervical cancer screening, and knowledge of HPV: a survey of primary healthcare smear-takers across Aotearoa New Zealand
CONCLUSIONS: The findings indicate knowledge deficits regarding HPV testing for cervical cancer screening and a desire for the provision of further education. Overall, respondents felt that no major barriers to implementing HPV self-testing would occur.PMID:38386856 | DOI:10.26635/6965.6308 (Source: New Zealand Medical Journal)
Source: New Zealand Medical Journal - February 22, 2024 Category: General Medicine Authors: Sarah Ingamells Rebecca Bell Janine Nip Carrie Innes Sarah Te Whaiti Alex Tino Lynn McBain John McMenamin Ben Hudson Melanie Gibson Bev Lawton Peter Sykes Source Type: research
Differentiated vulvar intraepithelial neoplasia long ‐term follow up and prognostic factors: An analysis of a large historical cohort
ConclusionsPatients with dVIN have a high risk of developing both primary and recurring VSCC. Early recognition, long-term follow up, and compliant ultrapotent topical corticosteroid treatment are recommended. (Source: Acta Obstetricia et Gynecologica Scandinavica)
Source: Acta Obstetricia et Gynecologica Scandinavica - February 22, 2024 Category: OBGYN Authors: Niccol ò Gallio,
Mario Preti,
Ronald W. Jones,
Fulvio Borella,
Linn Woelber,
Luca Bertero,
Sara Urru,
Leonardo Micheletti,
Federica Zamagni,
Federica Bevilacqua,
Pierluigi Tondo,
Benedetta Pollano,
Paola Cassoni,
Chiara Benedetto Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
Self-sampling for HPV testing in cervical cancer screening: A scoping review
Cervical cancer is the fourth most common cancer affecting women worldwide, following breast, colorectal, and lung cancers, with 569,847 new cases reported every year [1]. The estimated incidence is 13.1 per 100,000 women, and there is an estimated mortality rate of 6.9 per 100,000 cases [2]. The primary cause of this type of cancer is intraepithelial lesions induced by high-risk Human Papillomavirus (HPV) types, which are detected in 99.7 % of cervical cancer cases [3]. Early diagnosis is one of the primary methods for preventing the progression of intraepithelial lesions that carry a risk of developing into cervical c...
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - February 21, 2024 Category: OBGYN Authors: Tamy Colonetti, Maria Laura R. Uggioni, Ana Luiza M. Dos Santos, N áiade M. Uggioni, Laura U. Elibio, Eduarda L. Balbinot, Antonio J. Grande, Maria Inês da Rosa Tags: Review article Source Type: research
Factors Associated With Guideline-concordant and Excessive Cervical Cancer Screening: A Mixed Methods Study
National guidelines recommend cervical cancer screening with Papanicolaou (Pap) testing at 3-year intervals or with human papillomavirus (HPV) testing alone or HPV/Pap cotesting at 5-year intervals for average-risk individuals aged 30 –65 years. (Source: Womens Health Issues)
Source: Womens Health Issues - February 20, 2024 Category: Primary Care Authors: Rebecca B. Perkins, Lindsay Fuzzell, Paige Lake, Naomi C. Brownstein, Holly B. Fontenot, Alexandra Michel, Ashley Whitmer, Susan T. Vadaparampil Tags: Original Article Source Type: research
